Report Overview
The Global Pet Diabetes Care Market size is expected to be worth around US$ 6.0 Billion by 2035 from US$ 2.5 Billion in 2025, growing at a CAGR of 9.2% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 39.4% share with a revenue of US$ 1.0 Billion.
The global Pet Diabetes Care market is experiencing significant growth as pet owners increasingly prioritize the health and well-being of their companion animals. The rising prevalence of diabetes among pets, particularly dogs and cats, has fueled the demand for advanced diagnostic tools, insulin therapies, glucose monitoring devices, specialized diabetic food, and dietary supplements.
Growing awareness about preventive veterinary care, coupled with improvements in pet healthcare infrastructure, is encouraging early diagnosis and effective disease management. Veterinary hospitals and clinics continue to play a vital role in delivering specialized diabetes care, while online pharmacies and pet specialty stores are expanding access to essential products.
Technological advancements, including continuous glucose monitoring systems and user-friendly insulin delivery devices, are making diabetes management more convenient for both veterinarians and pet owners. Additionally, the increasing trend of pet humanization and higher spending on companion animal healthcare are supporting market expansion across developed and emerging economies.
North America remains the leading regional market due to high pet ownership rates, established veterinary services, and strong awareness of chronic pet diseases. Meanwhile, Asia-Pacific is expected to witness rapid growth as pet adoption rises and access to veterinary care improves.
With continuous innovation and increasing investment in animal healthcare, the Pet Diabetes Care market is expected to maintain steady growth over the coming years, creating opportunities for manufacturers, veterinary professionals, and pet care providers worldwide.
Click here for more information:
https://market.us/report/pet-diabetes-care-market/
Key Takeaways
The market was valued at US$ 2.5 billion in 2025 and is projected to reach US$ 6.0 billion by 2035, growing at a CAGR of 9.2%.
Dogs dominated the pet type segment, accounting for 59.9% of the market share.
Among product types, insulin held the largest share at 43.5%.
Veterinary hospitals and clinics led the distribution channel segment with a 55.7% revenue share.
North America emerged as the leading regional market, contributing 39.4% of the total market share.
Key Market Segments
By Pet Type
Dogs
Cats
Others
By Product Type
Insulin
Glucose Monitoring Devices
Syringes and Pen Needles
Diabetic Food
Dietary Supplements
Others
By Distribution Channel
Veterinary Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
Pet Specialty Stores
Top Key Players
Merck & Co., Inc. (Merck Animal Health)
Zoetis
BD (Becton, Dickinson and Company)
Boehringer Ingelheim International GmbH
Nova Biomedical
Allison Medical, Inc.
AccuBioTech Co., Ltd
i-SENS, Inc.
TaiDoc Technology Corporation
Emerging Trends in Pet Diabetes
- Rising Pet Obesity Driving Diabetes Cases: Pet obesity is becoming a major concern, increasing the risk of diabetes in companion animals. According to veterinary organizations, over 50% of pets are overweight, and obese cats are four times more likely to develop diabetes than healthy-weight cats. This trend is increasing demand for preventive care, weight management programs, and diabetic nutrition solutions.
- Growing Adoption of Continuous Glucose Monitoring: Veterinary clinics are increasingly using continuous glucose monitoring systems for diabetic pets. Modern CGM devices can record glucose levels every 5 minutes, generating around 288 readings in 24 hours, providing better treatment insights than occasional blood tests. This trend supports improved disease management and personalized insulin therapy.
- Increasing Focus on Early Diagnosis: Veterinarians are encouraging routine screening because diabetes is becoming more common in aging pets. Current estimates suggest that around 1 in 300 adult dogs and 1 in 230 cats in the United States have diabetes. Early diagnosis helps reduce complications and improves long-term health outcomes, boosting demand for diagnostic services.
- Expansion of Home-Based Diabetes Management: Pet owners are increasingly managing diabetes at home through insulin injections, glucose monitoring, and scheduled feeding plans. Home monitoring reduces frequent clinic visits while allowing better control of blood sugar levels. Digital monitoring devices and veterinary guidance are making long-term diabetes care more convenient for owners.
- Growing Demand for Specialized Nutrition: Veterinary experts emphasize that diet plays a critical role in diabetes management. Feeding pets two balanced meals approximately 12 hours apart helps maintain stable blood glucose levels. As awareness increases, demand for diabetic pet food, weight-control diets, and nutritional supplements continues to expand among pet owners. ## Key Use Cases of Pet Diabetes Care
**
- Blood Glucose Monitoring:** Blood glucose monitoring is the primary use case in pet diabetes management. Continuous glucose monitoring technology can collect 288 glucose measurements per day, allowing veterinarians to identify blood sugar patterns and adjust treatment plans more accurately than single-point testing methods.
- Insulin Therapy Management: Insulin therapy is widely used for diabetic dogs and cats that cannot regulate blood sugar naturally. Consistent insulin administration, combined with regular monitoring and veterinary supervision, helps pets maintain stable glucose levels and improves quality of life while reducing the risk of serious complications.
- Weight Management Programs: Weight control programs are an important use case because obesity is a leading diabetes risk factor. Veterinary guidance on diet and exercise helps reduce excess body weight, and in some overweight cats, achieving a healthy weight may even reverse the diabetic condition.
- Veterinary Diagnostic Services: Veterinary hospitals and clinics use blood and urine testing to diagnose diabetes and monitor treatment progress. Early identification of symptoms such as increased thirst, frequent urination, and weight loss enables timely intervention, helping prevent complications that can affect multiple organ systems.
- Preventive Pet Healthcare: Routine veterinary checkups and health screenings are increasingly used to detect diabetes risk in older or overweight pets. Preventive healthcare supports earlier treatment and better disease control, helping reduce emergency cases while promoting healthier and longer lives for companion animals. ** Conclusion:** The global Pet Diabetes Care market is poised for sustained growth, driven by the increasing prevalence of diabetes among companion animals, rising pet ownership, and growing awareness of preventive veterinary healthcare. Advances in insulin therapies, continuous glucose monitoring devices, and specialized diabetic nutrition are improving disease management and enhancing the quality of life for pets. Veterinary hospitals and clinics continue to dominate product distribution, while online channels are expanding accessibility. North America remains the leading market due to its advanced veterinary infrastructure, with Asia-Pacific emerging as a high-growth region. As pet humanization trends and investments in animal healthcare continue to rise, the market is expected to create significant opportunities for manufacturers, veterinary professionals, and pet care providers over the forecast period.
Top comments (0)